MedPath

Hamilton Health Sciences Corporation

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Comparison of Combination Therapy: Montelukast and Inhaled Steroid on Exercise Induced Bronchoconstriction

Phase 3
Completed
Conditions
Asthma
Interventions
First Posted Date
2007-04-19
Last Posted Date
2009-10-21
Lead Sponsor
Hamilton Health Sciences Corporation
Target Recruit Count
18
Registration Number
NCT00462592
Locations
🇨🇦

Hospital for Sick Children, Toronto, Ontario, Canada

🇨🇦

Hamilton Health Sciences-McMaster University, Hamilton, Ontario, Canada

Multifaceted Intervention to Improve Prescribing in Patients With Chronic Kidney Disease

Not Applicable
Conditions
Chronic Kidney Disease
First Posted Date
2007-03-13
Last Posted Date
2007-03-13
Lead Sponsor
Hamilton Health Sciences Corporation
Registration Number
NCT00446615
Locations
🇨🇦

Stonechurch Family Health Centre, Hamilton, Ontario, Canada

Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid

Phase 3
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: Placebo matched to doxycycline
Drug: Placebo matched to Rifampin
First Posted Date
2007-02-23
Last Posted Date
2018-03-19
Lead Sponsor
Hamilton Health Sciences Corporation
Target Recruit Count
100
Registration Number
NCT00439166
Locations
🇨🇦

St.Peter's Hospital, Hamilton, Ontario, Canada

Laparoscopic Bariatric Surgery to Treat Type 2 Diabetes in Obese Patients

Not Applicable
Terminated
Conditions
Type 2 Diabetes
Interventions
Procedure: Intensive Medical Management
Procedure: laparoscopic gastric bypass surgery
Procedure: laparoscopic adjustable gastric banding
First Posted Date
2007-01-30
Last Posted Date
2016-04-14
Lead Sponsor
Hamilton Health Sciences Corporation
Target Recruit Count
20
Registration Number
NCT00428571
Locations
🇨🇦

St. Joseph's Healthcare, Hamilton, Ontario, Canada

A Randomised, Controlled Comparison of Vitamin D Strategies is Acute Hip Fracture Patients

Phase 4
Completed
Conditions
Hip Fracture
Interventions
Drug: Placebo
First Posted Date
2007-01-19
Last Posted Date
2012-06-14
Lead Sponsor
Hamilton Health Sciences Corporation
Target Recruit Count
64
Registration Number
NCT00424619

Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole

Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2007-01-12
Last Posted Date
2015-09-23
Lead Sponsor
Hamilton Health Sciences Corporation
Target Recruit Count
58
Registration Number
NCT00421447
Locations
🇨🇦

McMaster University, Hamilton, Ontario, Canada

Strategies for Transfusion of Platelets (SToP)

Phase 3
Terminated
Conditions
Thrombocytopenia
First Posted Date
2007-01-11
Last Posted Date
2008-05-28
Lead Sponsor
Hamilton Health Sciences Corporation
Target Recruit Count
130
Registration Number
NCT00420914
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇨🇦

University Health Network, Toronto, Ontario, Canada

🇨🇦

McMaster University, Hamilton, Ontario, Canada

and more 3 locations

Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI

Not Applicable
Completed
Conditions
Diabetes Mellitus
Coronary Restenosis
First Posted Date
2006-12-15
Last Posted Date
2006-12-15
Lead Sponsor
Hamilton Health Sciences Corporation
Target Recruit Count
240
Registration Number
NCT00412126
Locations
🇨🇦

McMaster University/Hamilton Health Sciences, Hamilton, Ontario, Canada

A Multifaceted Intervention to Improve Hand Hygiene

Not Applicable
Completed
Conditions
Infection
Handwashing
Interventions
Behavioral: feedback
Other: usual care
Behavioral: Education
First Posted Date
2006-09-12
Last Posted Date
2018-10-26
Lead Sponsor
Hamilton Health Sciences Corporation
Target Recruit Count
1500
Registration Number
NCT00375037
Locations
🇨🇦

McMaster University Medical Centre, Hamilton, Ontario, Canada

🇨🇦

Hamilton General Hospital, Hamilton, Ontario, Canada

🇨🇦

Henderson Hospital, Hamilton, Ontario, Canada

Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)

Phase 2
Completed
Conditions
Purpura, Thrombocytopenic, Idiopathic
Interventions
Drug: Placebo
First Posted Date
2006-09-07
Last Posted Date
2012-06-07
Lead Sponsor
Hamilton Health Sciences Corporation
Target Recruit Count
60
Registration Number
NCT00372892
Locations
🇨🇦

McMaster Univerisity, Hamilton, Ontario, Canada

🇨🇦

London Health Sciences Centre, London, Ontario, Canada

🇨🇦

Grand River Regional Cancer Centre, Kitchener, Ontario, Canada

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath